CAMBRIDGE, MA / ACCESS Newswire / July 30, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the European Commission ...

Reports second quarter revenues of $0.1 billion, GAAP net loss of $(0.8) billion and GAAP EPS of $(2.13) Updates 2025 ...

Moderna Inc. shares are selling off Wednesday, after the Trump administration took aim at the science behind the ...

Doses of Moderna's updated COVID-19 vaccine are expected to begin arriving in Canada "within days," a spokesperson for the Public Health Agency of Canada says, although availability will depend on ...

The US Department of Health and Human Services is to cancel contracts and pull funding for some vaccines that are being ...

The Department of Health and Human Services (HHS) is winding down its mRNA vaccine development activities under the ...

The U.S. approved a new COVID-19 vaccine made by Moderna late Friday but with limits on who can use it — not a replacement for the company’s existing shot, but a second option.

Health Canada has authorized the use of an updated Moderna vaccine for COVID-19 ahead of an expected fall booster campaign. The reformulated vaccine — approved for those six months and older ...

Moderna's vaccine is approved for adults and children six months of age and older, the company said in a news release Tuesday. "With vaccines ready, Moderna will begin delivery of updated doses to ...